Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 3
1964 1
1965 1
1974 1
1980 2
1982 2
1983 5
1984 1
1985 2
1986 3
1987 4
1988 3
1989 4
1990 5
1991 5
1993 8
1994 4
1995 8
1996 4
1997 7
1998 10
1999 9
2000 8
2001 8
2002 15
2003 16
2004 23
2005 39
2006 54
2007 55
2008 75
2009 92
2010 107
2011 132
2012 148
2013 171
2014 233
2015 282
2016 243
2017 299
2018 322
2019 400
2020 432
2021 532
2022 561
2023 550
2024 581
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,914 results

Results by year

Filters applied: . Clear all
Page 1
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.
Xu B, Dong SY, Bai XL, Song TQ, Zhang BH, Zhou LD, Chen YJ, Zeng ZM, Wang K, Zhao HT, Lu N, Zhang W, Li XB, Zheng SS, Long G, Yang YC, Huang HS, Huang LQ, Wang YC, Liang F, Zhu XD, Huang C, Shen YH, Zhou J, Zeng MS, Fan J, Rao SX, Sun HC. Xu B, et al. Among authors: song tq. Liver Cancer. 2022 Nov 28;12(3):262-276. doi: 10.1159/000528034. eCollection 2023 Aug. Liver Cancer. 2022. PMID: 37601982 Free PMC article.
Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.
Lei Z, Ma W, Si A, Zhang Y, Yang F, Yu Q, Tang H, Xiao Q, Zhou J, Wang K, Tang Y, Han T, Yin G, Chen J, Liu X, Zhao H, Yu D, Luo T, Wang Q, Yan M, Mao X, Li J, Wang K, Li J, Zeng Y, Ding D, Chen T, Wu X, Xia Y, Wang K, Guo W, Zhu G, Gao S, Hüser N, Lau WY, Song T, Cheng S, Shen F, Cheng Z. Lei Z, et al. Among authors: song t. Aliment Pharmacol Ther. 2023 Sep;58(6):611-622. doi: 10.1111/apt.17623. Epub 2023 Jun 22. Aliment Pharmacol Ther. 2023. PMID: 37349908
An updated patent review of Mcl-1 inhibitors (2020-2022).
Liu J, Yin F, Wang Z, Song T, Zhang Z. Liu J, et al. Among authors: song t. Expert Opin Ther Pat. 2023 Jan-Jun;33(5):371-383. doi: 10.1080/13543776.2023.2219394. Epub 2023 Jun 14. Expert Opin Ther Pat. 2023. PMID: 37293764 Review.
Controversies in borderline ovarian tumors.
Seong SJ, Kim DH, Kim MK, Song T. Seong SJ, et al. Among authors: song t. J Gynecol Oncol. 2015 Oct;26(4):343-9. doi: 10.3802/jgo.2015.26.4.343. Epub 2015 Sep 23. J Gynecol Oncol. 2015. PMID: 26404125 Free PMC article. Review.
4,914 results